Physician profile
Douglas Benjamin Kirsch
NPI 1841304748
$26,071.83
in general payments reported to CMS, 2019-2025
8 companies · $11K in 2025
The $11K reported for 2025 was more than what 92% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $105 · 2022: $150 · 2023: $8,991 · 2024: $5,416 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Food and Beverage: $705 · Travel and Lodging: $303.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,809.17 |
| Food and Beverage | $704.68 |
| Travel and Lodging | $303.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Resmed Corp | $16,080.00 | 2024-2025 | |
| Idorsia Pharmaceuticals US INC | $9,075.95 | 2023-2024 | Quviviq |
| Inspire Medical Systems, INC. | $492.15 | 2022-2025 | Inspire |
| Avadel Cns Pharmaceuticals, LLC | $200.00 | 2025 | Lumryz |
| Eisai INC. | $105.00 | 2020 | |
| Jazz Pharmaceuticals INC. | $86.00 | 2025 | |
| Zoll Respicardia, INC. | $28.28 | 2023 | Remede System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4.45 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Kirsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.